FYI - For Your Innovation cover image

Shaping the Immunotherapy Landscape with Patrick Hwu, MD

FYI - For Your Innovation

00:00

How to Accelerate the Cost Declines of Cell Therapy

Regulatory approval is a major challenge for cell therapies./nArtificial intelligence and CRISPR are improving the timeline and potential pricing of cell therapies./nLowering the cost of cell therapies can encourage pharmaceutical companies to continue working on potentially curative therapies./nScalability can be achieved through involving bioengineers and automating manual processes./nMaking cell therapies more effective and reducing the number of cells needed can further cut costs.

Play episode from 16:51
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app